RAP 0.00% 20.5¢ resapp health limited

Great start, only concern is it doesn't specify how quickly it...

  1. 195 Posts.
    lightbulb Created with Sketch. 40
    Great start, only concern is it doesn't specify how quickly it will roll out except for "over the next few months" now that integration has been completed.
    Hopefully nothing but otherwise a solid announcement.

    $5-$10 could be based on a bulk usage of the item as further tests change the scope, or depending on subsidies from medicare, etc etc.. many options but the range is great and within expected guidance from the company.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.